58076-33-8

Basic information

• Product Name: Benzenesulfonyl chloride, 4-(pentyloxy)-
• CAS NO: 58076-33-8
• Molecular Formula: C11H15ClO3S
• Molecular Weight: 262.757
• Mol File: 58076-33-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzenesulfonyl chloride, 4-(pentyloxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonyl chloride, 4-(pentyloxy)-(58076-33-8)
• EPA Substance Registry System: Benzenesulfonyl chloride, 4-(pentyloxy)-(58076-33-8)

Safety Data

• Hazardous Substances Data: 58076-33-8(Hazardous Substances Data)

Upstream product

• 2050-04-6 (pentyloxy)benzene 
• 108-95-2 phenol 
• 110-53-2 1-Bromopentane 
• 139-02-6 sodium phenoxide 
• 825-90-1 sodium p-hydroxybenzenesulfonate 

Downstream Products

• 91216-77-2 4-pentyloxyphenylsulfonyl hydrazide 
• 1170071-73-4 N-(2-aminoethyl)-4-(pentyloxy)-benzenesulfonamide 
• 1160494-36-9 1-(ethynylsulfonyl)-4-(pentyloxy)benzene 
• 101450-51-5 1-(4-pentyloxy-benzenesulfonyl)-piperidine 

Relevant articles and documents

METHODS OF USING SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS

Methods of using semi-synthetic glycopeptides of formula I-XIV having antibacterial activity are described.

SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBACTERIAL ACTIVITY

Semi-synthetic glycopeptides having antibacterial activity are described. Also described are processes of preparing such semi-synthetic glycopeptides by chemical modification of a glycopeptide (Compound A, Compound B, Compound H or Compound C) or the monosaccharide made by hydrolyzing the disaccharide moiety of the amino acid-4 of the parent glycopeptide in mild acidic medium to give the amino acid-4 monosaccharide; protection of the amino groups in the molecule; and conversion of the acid moiety on the macrocyclic ring of these scaffolds to certain substituted amides. Also included are the process of conversion of the amide group in amino acid-3 on these scaffolds to various acylureas, acylamide, acylsulfonamide, acylsulfonylurea derivatives and aminomethylation with substituent containing sulfonamide or acylsulfonamide group on amino acid-7 through Mannich reaction procedures. Further provided herein are pharmaceutical compositions containing the compounds, and methods of use of the compounds for the treatment and/or prophylaxis of diseases, including bacterial infections.

Keratinocyte growth inhibitors and hydroxamic acid derivatives

This invention relates to a keratinocyte-proliferation inhibitor comprising as active ingredient a compound having an activity of inhibiting the solubilization of heparin-binding EGF-like growth factor bound to cell membranes and a compound of the formula (I); or pharmaceutically acceptable salt thereof, wherein R1, R2, R3 are hydrogen atom or alkyl and X is substituted benzene or the like.